Kelly John Alexander's Form 4/A amendment
AmendedPrecision Biosciences Inc (DTIL) · filed Oct 27, 2023
- Accession no.
- 0001209191-23-053784
- Filed
- Oct 27, 2023, 4:55 PM ET
- Trade date
- Aug 18, 2023
- Filing delay
- 70 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 22, 2023
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $43.2K. It was filed 70 days after the trade.
This amendment replaces 0001209191-23-046874 (filed Aug 22, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kelly John AlexanderCIK 0001590030 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2023 | Common Stock | PPurchaseAcquired | +90,000 | $0.48 | +$43,200 | 383,340 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.